Alexander Julian Swistel, M.D.
Dr. Alexander Swistel is Associate Professor of Clinical Surgery and Associate Attending Surgeon at NewYork-Presbyterian/Weill Cornell Medical Center and an internationally-recognized breast surgeon who pioneered many of the newest advances in breast cancer treatment.
Dr. Swistel graduated from Harvard University and completed his medical school training at Brown University Medical School. He did his surgical residency at St. Luke’s-Roosevelt Hospital Center, and then completed the two-year surgical oncology fellowship at the Memorial Sloan Kettering Cancer Center. He joined the Surgical Attending staff at the St. Luke’s-Roosevelt Hospital Center and subsequently became their first Chief of Breast Surgery. In 1996, he was recruited by New York Hospital and joined the attending staff in surgery. There he was instrumental in coordinating efforts to develop the Weill Cornell Breast Center and became the Director of the Program. He also started their Breast Surgical Service and became its first director. Currently, he is Associate Clinical Professor of Surgery at the Weill Cornell Medical College and Associate Attending in the Department of Surgery and former Chief of the Section of Breast Surgery.
Dr. Swistel is an acknowledged expert in the field of minimally-invasive breast cancer surgery. He has pioneered many improvements in the delivery of breast cancer care for his patients over the years. He has consistantly been included on multiple Best Doctor lists, is listed in Who’s Who in America and is widely quoted as an expert in the field by the media.
In 1986, he established the first Comprehensive Breast center in Manhattan at the St. Luke’s Hospital. This served as a model for subsequent breast centers throughout the city including the Lauder Center at Sloan Kettering and the present Weill Cornell Breast Center. Recognizing that the minority population sometimes had difficulty in accessing good breast care, he received a special grant from the state to focus on screening minority patients. This program was adopted by the New York State Legislature and continues to be funded to this day. He first developed an early protocol using laser guided destruction of small breast tumor as a way to minimize surgical scars. Later, he performed the first skin sparing mastectomy in New York City in 1991. That technique did much to minimize the surgical defect related to standard radical mastectomy and the technique was combined with immediate reconstruction. He was one of the first physicians in New York to perform sentinel lymph node biopsy, then a new technique for minimizing axillary surgery for breast cancer patients.
Dr. Swistel has been in the forefront of oncoplastic surgery that combines optimal cancer surgery principles for cure along with cosmetic techniques to minimize scars. He initiated the first academic based oncoplastic surgery program in the tri-state area. He introduced nipple sparing mastectomy to NewYork-Presbyterian Hospital and improved on the surgical technique with an infra -mammary approach which leaves the patient with virtually no visible scar. Along with the radiation oncologists, Dr. Swistel began the first successful intra-operative radiation therapy for early stage breast cancer in New York City. He has lectured widely on the topic of breast cancer surgery and prevention strategies and has developed a high risk program at Weill Cornell for patients who are at elevated risk for developing breast cancer. He has published widely in peer-reviewed journals and is on the editorial board of a number of those publications. Dr. Swistel was on the founding medical board for New York’s Komen organization for the “Race for the Cure” and remains on the National Medical Board for the Young Survivor’s Coalition. He is past President of the New York Metropolitan Breast Cancer Group, which is the oldest and largest regional group of breast cancer specialists in the nation and He is a member of multiple specialized cancer organizations. He has received many honors and awards in recognition of his important contributions to the advancement of minimally invasive procedures for breast cancer. In 2014, Dr. Swistel received a Lifetime Achievement Award from the Cancer Research and Treatment Fund for his pioneering work in breast cancer surgery.
Alexander J. Swistel, M.D., a nationally-renowned breast surgeon, has pioneered many of the newest advances in minimally-invasive breast cancer treatment.
Dr. Swistel graduated from Harvard University and received his medical degree from Brown University School of Medicine in 1975. He completed his surgical residency at St. Luke's-Roosevelt Hospital Center and a two-year surgical oncology fellowship at the Memorial Sloan-Kettering Cancer Center. At the completion of his fellowship, Dr. Swistel returned to St. Luke's as an Attending Surgeon and subsequently became the Chief of Breast Surgery.
In 1996, he was recruited by New York-Presbyterian Hospital to strengthen the breast service and joined the attending staff in surgery. Dr. Swistel's visionary leadership was instrumental in developing and launching the Weill Cornell Breast Center and he became the Director of the Program and served for Chief of Breast Surgery for over 14 years. He is Associate Professor of Clinical Surgery at Weill Cornell Medical College, Associate Attending at New York-Presbyterian Hospital's Department of Surgery.
Dr. Swistel has pioneered many significant improvements in the delivery of breast cancer care that have greatly benefited patients and offered new, less invasive treatment options for women with breast cancer. He developed an early protocol using laser-guided destruction of small breast tumors as a way to minimize surgical treatment of breast cancers. He was the first surgeon in New York to perform a skin-sparing mastectomy in 1991. That technique revolutionized standard radical mastectomies. When combined with immediate reconstruction, it allowed for a significantly improved cosmetic outcome, with no decrease in survival. In fact, the quality of survival was enhanced.
He continues to pioneer techniques in surgery that provide effective removal of tumors with reconstructive techniques that leave the patients without visible scars and excellent tumor therapy. This vision has culminated in the establishment of a specialized center of oncoplastic surgery, where teams of surgeons combine the latest techniques for tumor removal along with reconstructive options. This leaves patients with no visible reminder of the breast cancer, better cosmetic results, and reduced risk. Many studies show a huge psychological benefit to woman who undergo oncoplasty.
In 1986, he established the first Comprehensive Breast Center in Manhattan at St. Luke's Hospital. That center served as a model for subsequent breast centers throughout the city. Recognizing that minority populations often have difficulty accessing good breast care he received a special grant from New York State to focus on screening of minority patients. This program was adopted by the New York State legislature and continues benefiting women today.
Dr. Swistel was one of the first physicians in New York to pioneer sentinel lymph node biopsy, a new technique for minimizing auxiliary surgery. He currently runs a high-risk surveillance program at the Weill Cornell Breast Center for patients who are at elevated risk for developing breast cancer.
Dr. Swistel is past President of the Metropolitan Breast Cancer Group, which is the oldest and largest regional group of breast cancer specialists in the nation. He is a fellow of the New York Academy of Medicine. Dr. Swistel is a member of many professional societies, including the American College of Surgeons, Brown Medical Alumni Association, New York County Medical Society, Association for Academic Surgery, Society of Head and Neck Surgeons, American Society of Clinical Oncology, New York Metropolitan Mammography Society, American Society of Breast Diseases and the American Society of Breast Surgeons.
Insurance Plans Accepted
The following represents most of the managed care plans accepted by this physician. If your insurance carrier does not appear here please contact the physician’s office as they may have individual contracts not included on this site.
* indicates this physician is no longer accepting new patients with this insurance plan.
- Aetna - Weill Cornell [POS]
- Empire Blue Cross/Blue Shield [PPO]
- Empire Blue Cross/Blue Shield [Mediblue (Senior)]
- Empire Blue Cross/Blue Shield [EPO]
- Empire Blue Cross/Blue Shield [HMO]
- Fidelis Care
- Health Plus - Amerigroup [CHP]
- Rockefeller University - CoreSource
- United Empire
1. Buonapane E., Collier, T., Geller, T., Giangrosso, T., Labbok, M., Swistel, A.J., Gottlieb, M.S.: Screening for Prevalence of the Arterial Hypertension Recognized and Unrecognized with Evaluation of Blood Pressure Control In an Urban Population: Clin. Res., 23: 463, 1973.
2. Burrows, W.B., Pierce, J.C., Hashim, G.A., Ramey, W.G,, Swistel, A.J., Lee, D.H., Fitzpatrick, H.F.: Cell-Mediated Immunity to Donor Antigens in Renal Allogaft Recipients. Surgery, 83 (6): 741 Â 745, 1978.
3. Swistel, A.J., McCabe, R.E., Lorieo, D.R., Wildstein, A., Pierce, J.C., Fitzpatrick, H.F,: The Enhancing Effect of Donor Pretreament (C-MP) and Low Dose Immunosuppression (LDI) in Dogs. Proc. Dial, and Trans. Forum, VIII: 93-95, 1978.
4. Ramey, W.G., Hashim, G.A., Burrows, W.B., Swistel, A.J., Munther, A.S., Fitzpatrick, H.F.: Cell-Medicated Immunity to Breast Cancer: Tumor Antigen-Sensitive Circulating T-Lymphocytes. Fed. Proc., 38: 993, 1979.
5. Swistel, A.JU., McCabe, R.E., Lorieo, D.R., Wildstein, A., Fitzpatrick, H.F.: The Effect of Donor Pretreatment and Low Dose Immunosuppression on the 24-Hour Preserved Canine Renal Allograft. Trans. Proc, Vol. XI, (3): 1679 Â1675, 1979.
6. Ramey, W.G., Hashim, G.A., Burrows, W.B., Swistel, A.J., Munther, A.S., Fitzpatrick,k H.F.: Detection of Breast Tumor Antigen-Sensitive Circulating T-Lymphocytes by Antigen-Stimulated Active Rosette Formation. Cancer Research, 39: 4796 Â4801, 1979.
7. Ramey, W.G., Hashim, G.A., Munther, A.S., Swistel A.J., Burrows, W.B., Fitzpatrick, H.F.: Diagnosis, Stage and Prognosis of Lung Carcinoima by Preoperative Assay of Lung Tumor Antigen-Sensitive T-Lymphocytes. J. Thorac. And Cardiovasc. Surgery. 80 (5): 656 Â660, 1980.
8. McCabe, R.E., Swistel, A.J., Lorieo, D.R., Fitzpatrick, H.F.: Prolongation of Canine Renal Allografts in the Immunosuppressed host by Donor Pretreatment with Cytolytic Agents. Trans. Proc, Vol. XII, (2): 355 Â 57, 1980.
9. Ramey, W.G., Hashim, G.A., Munther, A.S., Swistel, A.J., Burrows, W.B., Fitzpatrick, H.F.: Circulating Lung, Tumor Antigen-Sensitive T-Lymphocytes: Detection in the Early Stages of Lung Cancer. Surgery, 88: 202-207, 1980.
10. Swistel, A.J., Lorieo, D.R., McCabe, R.E.: The Effect of Donor Pretreatment on Tubular Function of the Preserved Canine Allograft: Organ Preservation, Basic and Applied Aspects. Chap. 41, MPP-Press Limited, Internal Medicine Publishers, 1982.
11. Ramey, W.G., Hashim, G.A., Munther, A.S., Swistel, A.J., Fitzpatrick, H.F., Miller, R.E.: Prediction of Breast Carcinoma Recurrence by Postoperative Assay of Tumor-Sensitive T-Lymphocytes. Feb. Proc., 40: 1039, 1981.
12. Swistel, A.J., Hancock, C.H., Bading, J.R., Leyland-Jones, B., Raaf, J.H.: Improved VX-2 Tumor Response After Intra-Arterial Versus Intravenous Adriamycin: Pharmacokinetic and Hemodynamic Verification. Surgical Forum, XXXIV: 443-445, 1983.
13. Swistel, A.J., Bading, J.R., Raaf, J.H.: Comparison of Intra-Arterial Versus Intravenous Adriamycin in the Rabbit VX-2 Tumor System. Cancer, 53 (6): 1394-1404, 1984.
14. Fodor, P., Swistel, A.J.: Chest Wall Deformity Following Expansion of Irradiated Soft Tissue for Breast Reconstruction. Journal of the New York State Medical Society, 1988.
15. Simmons, R.M., Kersey Fish, S., Gayle, L., La Trenta, G.S., Swistel, A.J., Christos, P., Osborne, M.P.: Local and Distant Recurrence Rates in Skin Sparing Mastectomies Compared with Non-Skin Sparing Mastectomies. Annals of Surgical Oncology 6: 676-681, 1999.
16. Chiu, A., Swistel, A.J., Hoda, S.A.: Sentinel Lymph Node: One Year
Experience. Modern Pathology, 12: 17A, 178, 1999.
17. Chiu, A., DeLellis, R.A., Swistel, A.J., Hyjek, E., Hoda, S.A.: Frozen Section Examination of Sentinel Lymph Nodes. Is It Predictive of Status of Other Axillary nodes? Modern Pathology, 13: 19A, 89, 2000.
18. Chiu, A., DeLellis, R.A., Swistel, A.J., Hyjek, E., Hoda, S.A.: Axillary Sentinel Lymph Node Biopsy is More Accurate in T1 Than Larger Breast Cancers. Modern Pathology, 13: 19A, 90, 2000.
19. Hyjek, E., Chiu, A., Chadburn, A., Swistel, A.J., Hoda, S.A., DeLellis, R.A.: Rapid Immunostaining with Cytokeratin of Sentinel Lymph Nodes. Modern Pathology, 13 : 223A, 1316, 2000.
20. Shaikh, N., LaTrenta, G., Swistel, A.J., Osborne, M.: Detection of Recurrent Breast Cancer After Tram Flap Reconstruction. Annals of Plastic Surgery, December 2001.
21. Chiu, A., Hoda, S.A., Swistel, A.J., Rosen, P.P.: Sentinel Lymph Nodes Positive by Immunohistochemistry Only. Breast Journal. In Press.
1. Swistel, A.J., McCabe, R.E., Lorieo, D.R., Wildstein, A., Pierce, J.C., Fitzpatrick, H.F.: The Enhancing Effect of Donor pretreatment (C-MP) and Low Dose Immunosuppression (LDI) in Dogs. Clinical Dialysis and Transplant Forum, VIII, New Orleans, Louisiana, November, 1978.
2. Swistel, A.J., Bading, J.R., Raaf, J.H.: Comparison of Intra-Arterial Versus Intravenous Adriamycin in the Rabbit VX-2 Tumor System. Society of Surgical Oncology, Denver Colorado, May 1983.
3. Swistel, A.J., Hancock, C.H., Bading, J.R., Leyland-Jones, B., Raaf, J.H.: The Pharmacokinetics of Intra-Arterial and Intravenous Adriamycin in the Rabbit VX-2 Tumor System. Surgical Forum XXXIV, Fall Meeting, American College of Surgeons, Atlanta, Georgia, October 1983.
4. Swistel, A.J., Shiu, M.H., Myskowski, P.L., Brennan, M.F.: Malignant Melanoma in Association with Lympho-Reticular Malignancies. First International Melanoma Conference, Venice, Italy, May 1985.
5. Swistel, A.J.: Update on Breast Cancer Â New Techniques, Research and Treatment. Time Life ÂRun for Life,Â New York, New York, January, 1995.
6. Swistel, A.J.: Update on Breast Surgery 6th Annual Symposium, Section on Breast Cancer. Sociedad Medica Dominicana, Inc., New York, New York, September, 1995.
7. Swistel, A.J.: Surgical Grand Rounds, Visiting Faculty, DCIS; Radical Surgery for Non-Radical Disease? Wycoff Heights Hospital, Brooklyn, New York, December, 1997.
8. Swistel, A.J.: Teaching Faculty, Cornell-Salzburg Seminars. New Techniques in Breast and Thyroid Cancer Surgery, Salzburg, Austria, February, 1998.
9. Swistel, A.J.: New Techniques in Breast Cancer Surgery - Sentinel Lymph Node and Stereotactic Breast Biopsy, Management of DCIS. Teaching Faculty, New York Presbyterian Hospital, Department of Radiology Annual Course, Cayman Island, March, 1998.
10. Swistel, A.J.: OB-Gyn Grand Rounds. Guest Speaker, New Developments in Breast Cancer Surgery, New York Presbyterian Hospital Â Weill Cornell Campus, New York, New York, September, 1999.
11. Chiu, A., Hoda, S., Swistel, A.J., Nowak, E., DeLellis, R.A., Rosen, P.: Sentinel Nodes Positive By Cytokeratin Only: Results in 20 Node Cases. The U.S. and Canadian Academy of Pathology, San Francisco, December, 1999.
12. Swistel, A.J.: Surgical Grand Rounds. Guest Presentation, New York United Hospital Center. Sentinel Node Biopsy for Breast Cancer, New York, New York, January, 2000.
13. Swistel, A.J., Kinne, D., Bleiweiss, F.: Sentinel Lymph Node Biopsy, Role in DCIS-LCIS and Pathologic Viewpoint. Moderator, New York Metropolitan Breast Cancer Group, New York, New York, February, 2000.
14. Swistel, A.J.: Sentinel Lymph Node Mapping, The 13th I. Joseph Aprile Distinguished Lecturer. Catholic Medical Center of Brooklyn and Queens, Brooklyn, New York, April, 2000.
15. Swistel, A.J., Hoda, S., Simmons, R.A., Nowak, E., Osborne, M.D.: Role of Cytokeratin Positive Cells in Sentinel Lymph Nodes in Breast Cancer Surgery. American Society of Breast Surgeons, Charleston, South Carolina, April, 2000.
16. Swistel, A.J.: Update in Modern Breast Cancer Therapy. American Association of Operating Room Nurses, New York Chapter, New York, New York, April, 2001.
17. Swistel, A.J.: Surgery in the 21st Century: The Centennial Alumni Celebration, Cornell Medical School Reunion, New York, New York, October, 2001.
18. Swistel, A.J.: Advances in Breast Cancer Surgery, Guest Lecturer. Women at Risk, New York Presbyterian Hospital, Columbia-Presbyterian Medical Center, New York, New York, May, 2001.
19. Swistel, A.J., Smith, S.: Screening for Breast Cancer, Breast Cancer Update. Curriculum Course for Primary Care. Columbia College of Physicians, New York, April, 2002.
Honors and Awards
Lifetime Achievement Award, 2014 from the Cancer Research and Treatment Fund
2007-2014 Top Cancer Doctors in America, Castle Connolly; 2011-2014 Top Doctors in the Tri-State Area, New York Magazine; 2007-2014 Best Doctors in America.
Komen Award for Patient Video Presentation of Preparation for Breast Cancer Surgery, 2001, 2002.
Sentinel Lymph Node Mapping, The 13th I. Joseph Aprile Distinguished Lecturer. Catholic Medical Center of Brooklyn and Queens, April 2000.
New York State Grant to Form a Breast Cancer Detection Program, St. Lukes Hospital, 1986.
- Onco-Plastic Surgery
- General Surgery
- Breast Surgery
- Breast Cancer
- Breast Disease
- Sentinel Node Biopsy For Breast
- Breast Lumpectomy
- Mastectomy Reconstruction
- Sentinel Node
- Breast Cancer Surgery
- Skin Sparing Mastectomy
- Nipple Areola Sparing Mastectomy
- Minimally Invasive Breast Surgery
- High Risk Breast Disease
- B.A., Harvard University, 1971
- M.D., Brown University School of Medicine, 1975